Stories

Symposium underscores READDI’s role in ‘marathon of preparedness’

09.27.23

Symposium underscores READDI’s role in ‘marathon of preparedness’

Drugs that broadly target virus families are essential when defending against Disease X, says blockbuster roster of speakers.

Expert group makes strong case for medical-countermeasures network

09.18.23

Expert group makes strong case for medical-countermeasures network

A bipartisan opportunity to strengthen America’s pandemic security

08.28.23

A bipartisan opportunity to strengthen America’s pandemic security

How READDI develops drugs for viruses that don’t yet exist

08.21.23

How READDI develops drugs for viruses that don’t yet exist

READDI contributes to alliance in accelerating antiviral drug development

07.20.23

READDI contributes to alliance in accelerating antiviral drug development

READDI receives $65M grant from NIH to establish Antiviral Drug Discovery (AViDD) Center

05.20.22

READDI receives $65M grant from NIH to establish Antiviral Drug Discovery (AViDD) Center

READDI receives $18M in from the N.C. General Assembly

02.11.22

READDI receives $18M in from the N.C. General Assembly

READDI awarded $5M by RTI’s Forethought Research Collaboration Challenge

11.08.21

READDI awarded $5M by RTI’s Forethought Research Collaboration Challenge

The best time to fight a global pandemic is now.

And always.